Biosimilar Education And Innovation Bills Head To Biden’s Desk
Senators, Industry And Regulators Urge President To Pass Bipartisan Bills
The Advancing Education on Biosimilars Act and the Ensuring Innovation Act will be looked at by the US President Joe Biden, after receiving the approval of both the Senate and the House of Representatives. The bills are aimed at lowering prescription drug costs and saving overall healthcare costs.
